Abstract: Previous studies in this laboratory have demonstrated that peptide YY (PYY) administration to turkey poults at d25 of incubation enhances intestinal Na-dependent active glucose uptake. This study was designed to further characterize the ontogeny of glucose transport in embryonic and hatchling poults and to investigate the effects of PYY on this process during development. In Trial 1, 20 turkey eggs were randomly selected at days 20, 23, and 26 of incubation, as well as the day of hatch. Hatchlings were cervically dislocated and the body weight, jejunal length and jejunal weight were recorded. Jejunal glucose uptake was estimated by measuring H-3-O-methyl-D-glucose accumulation in 2 mm jejunal rings in vitro. Jejunal O 3 2 consumption was measured in vitro on jejunal rings using an O probe. In Trial 2, 40 turkey eggs were 2 randomly selected at days 20, 23 and 25 of incubation and injected, via the air sac, with either 0.9% saline or 0.9 % saline plus 400 µg PYY/kg egg weight. Embryos from each treatment were harvested on days 23, 26 and day of hatch. Measurements and analyses on jejunal tissue were conducted as in Trial 1. In Trial 2, embryonic weight and jejunal weight adjusted for body weight increased (p<0.05) with stage of incubation, while adjusted jejunal length decreased (p<0.01). Active and total glucose uptake and jejunal O 2 consumption increased with age (p<0.05). The energetic efficiency of glucose uptake increased (p<0.05) between d26 and hatch. In Trial 2, PYY failed to significantly affect body or jejunal weight, glucose absorption, and O consumption at any stage of development. PYY did however, decrease the efficiency of glucose 2 uptake at d26 and at hatch (p<0.05). In contrast to earlier investigations using higher dosages of PYY, this study demonstrated that in ovo PYY administration at 400 µg/kg egg weight has little effect of jejunal function in turkeys.
Introduction
Previous investigations have demonstrated that peptide YY (PYY), a gastrointestinal peptide hormone and a member of the pancreatic polypeptide family o f hormones which includes neuropeptide Y and pancreatic peptide (Larhammar, 1996) , enhances intestinal glucose absorption (Bird et al., 1996; Coles, 1999) . Peptide YY is produced by enterendocrine cells in the lower intestine in response to the presence of free fatty acids in the lumen of the distal small intestine (Larhammar, 1996; Hallden and Aponte, 1997) . Bird et al. (1996) reported that PYY administration enhanced active glucose transport in the mouse without significant changes in energy expenditure suggesting that PYY may also enhance the efficiency of intestinal glucose absorption. We have previously demonstrated that in ovo administration of PYY increased post-hatch jejunal active glucose transport when administered at 900 µg/kg egg weight in British United Turkey poults (BUT) and 600
Materials and Methods

µg/kg egg weight in Egg Line and Nicholas poults
Commercial turkey eggs (BUT; British United Turkeys, . Additionally, Coles et al. (1999, UK) were obtained from Prestage Farms (Clinton, NC). 2000) have reported that broilers and turkey poults from Developing eggs and poults were treated in accordance eggs treated with PYY demonstrate enhanced growth with guidelines of the North Carolina State University and feed conversion during the first week post-hatch.
Institutional Animal Care and Use Committee. In Trial, 1
Digestive and absorptive processes in turkey poults are not fully developed at hatch (Suvarna et al., 2005) . The inability to fully utilize these processes may significantly contribute to an increased post-hatch mortality and decreased performance (Krogdahl and Sell, 1989; Nitzan et al., 1991; Nir et al., 1993) . Croom et al. (1999) suggested that in ovo administration of PYY in ovo may increase the maturation of glucose and other intestinal nutrient transporter systems in incubation and at hatch and e nhance nutrient absorption during this critical period of post-hatch growth and development. To date there have been no studies on the effect of PYY on glucose absorption and intestinal growth during incubation. The objective of this study was to determine the effects, in turkey poults, of in ovo PYY administration on the ontogeny of jejunal glucose absorption at various stages of embryonic development and at one day posthatch.
91 fertile eggs were incubated in a forced draft incubator pieces of jejunum from each sample. Total glucose with automatic egg turner at 38-39 C. On d20, d23, and uptake was estimated using transport buffer with H-3-o d26 of incubation, as well as on the day of hatch (d28), O-MG. Passive glucose transport was estimated using 20 embryos or poults were euthanized by cervical transport buffer with 1mM phlorizin (phloretin-2'-b-Ddislocation and weighed. Embryos and poults the small glucoside; Sigma Chemical, St. Louis, MO), a intestine was removed from the body cavity and the competitive inhibitor that irreversibly binds to the Na+-intestinal mesentery gently dissected away. The dependent active glucose transporter (Brot-Laroche and intestinal lumen was flushed free of any residual digesta Alvarado, 1983) . Assays for total and passive glucose using 4 C HEPES buffer (25 mM HEPES, 4.8 mM KCl, transport were conducted at 37 C. A third incubation with o 140 mM NaCl, 2.5 mM CaCl , 1.2 mM MgSO , 1.2 mM transport buffer plus phlorizin was conducted at 4 C to 2 4 KH PO , pH 7.4) and then placed in the ice-cold buffer. measure nonspecific glucose uptake. Assays were 2 4
The duodenum, jejunum (defined as the tissue stopped by transferring intestinal rings into 3 mL of iceimmediately distal to the pancreatic ducts and proximal cold 300 mM mannitol. H-3-O-methyl-D glucose was to the yolk sac stalk), and ileal segments were isolated extracted from the tissue by incubation in 2 mL o f and the unstretched lengths and blotted weights were trichloroacetic acid (2.5 g/L) at room temperature for 45 recorded for each segment. The jejunum was folded into min in a Dubnoff metabolic shaking water bath set at 60 fourths to identify the proximal second quarter, and this cycles/min. Intestinal rings were removed, blotted, and segment was isolated in order to measure jejunal weighed. The extract was centrifuged at 2000 x g for 10 glucose uptake and tissue oxygen consumption. The min at 4 C, and then 1 mL of the decanted supernatant samples were kept in 4 C HEPES buffer solution prior to was dispersed in 5 ml of Ecolite (+) scintillation cocktail o the assays.
(ICN Biomedicals, Cleveland, OH) and counted for 10 In Trial 2, BUT eggs were incubated as in Trial 1, but min in a Beckman LS-7500 scintillation counter were randomly divided into two treatment groups. The (Beckman Instruments, Fullerton, CA). Duplicate control eggs were injected with 0.1 mL of 0.9% saline aliquots (100µL) of transport buffer, with and without into the egg air space on d20, d23, and d25 o f phlorizin, containing approximately 2.8 kBq H-3-O-MG incubation (controls) or with 0.1 ml of 0.9% plus 400 µg and a blank were counted with each set of samples. human recombinant PYY(treatment; Quality Controlled Biochemicals, Hokinton, MA). For each group, 20 eggs Jejunal oxygen consumption assay: Intact jejunal O were injected each day of incubation and incubated an uptake was measured according to the procedures additional 3 days. On d23, d26, and hatch, respectively, described by Fan et al. (1996) for murine tissue using an embryos and poults were euthanized by cervical oxygen monitor and incubation bath fitted with an oxygen dislocation and weighed. Intestinal tissue was isolated sensor (Yellow Spring Instruments model 5300, Yellow and duodenal, jejunal, and ileal weights and Springs, OH). Oxygen uptake measurements were only unstretched lengths were recorded as in Trial 1. Tissue conducted on jejunal samples at d26 and at hatch due preparation for glucose transport and tissue oxygen to the small size of the embryos and intestinal tissue consumption was the same as in Trial 1. early in the incubation period. Jejunal segments were
Jejunal glucose transport assay: The jejunal glucose buffer. Segments were blotted, weighed and transferred transport assay was modified from the protocol of Fan et to reaction chambers containing 4 ml of reaction media al. (1996) . The isolated jejunal segments were cut into composed of 11 g M199, (Sigma Chemical; St. Louis, 2 mm rings to yield tissue pieces of approximately 20-40 MO), 5.96 g HEPES, and 0.36 g NaHCO in 0.1 L H O, mg in wet weight. The tissue rings were inverted to pH 7.4, at 37 C. The samples were constantly stirred optimally expose the villus surface to the assay and the oxygen uptake recorded for 3 min using a dual solutions and stored in 4 C HEPES buffer solution prior channel chart recorder. MBq/ml, DuPont NEN, Wilmington, DE). uptake for the entire jejunum was calculated b y To differentiate active from passive glucose transport, multiplying O consumption rate per gram of jejunum by assays were conducted in triplicate from three adjacent 50% of the small intestine weight, as described by Fan (1996) . Oxygen consumption of active glucose result of decreases in active glucose transport (Table 2) . uptake is presented as nmole O consumed/min/g Passive glucose transport was decreased (p<0.05) by 2 tissue. The apparent energetic efficiency (APEE; nmole PYY administration at d23 of incubation. Jejunal oxygen ATP expended / nmole active glucose uptake) was consumption was not affected by PYY administration. determined as described by Bird et al. (1994) and
The APEE of glucose uptake from the jejunum was Croom et al. (1998) .
calculated for both control and PYY treated eggs. As in Data were statistically analyzed using the General Linear Trial 1, the value decreased from d26 to hatch, (p<0.05) Models Procedure of SAS (1988) with treatment as the representing an increase in overall efficiency of active main effect. Preplanned comparisons for Trial 1 glucose uptake (Fig. 1) . In contrast, PYY administration were: d20 versus hatch, d23 versus hatch; and d26 decreased the efficiency of glucose transport a s versus hatch. Preplanned comparisons for Trial 2 were:
compared to control at both d26 and hatch (p<0.08 and d23 control versus d23 PYY; day 26 control versus d26 p<0.02 for d26 and hatch, respectively). PYY and day of hatch control versus day of hatch PYY. Differences were considered significant at p<0.05.
Results
pattern of jejunal growth and glucose transport Trial 1: Embryonic body weight increased significantly processes in BUT turkey embryos (Table 1) . During d23 with each stage of incubation, most notably from d20 to d26 of incubation, jejunal growth and function i s and d23 to hatch (p<0.001; Table 1 ). Jejunal weight, characterized by increases in tissue weight relative to adjusted for embryonic weight (Table 1) , increased with length (intestinal density) and active glucose transport days of incubation (p<0.001). Jejunal length adjusted for relative to passive transport. In the interval between day embryonic weight decreased (p<0.001) between d20, 26 and hatch, large increases occur in jejunal growth, d23 of incubation and hatch while increasing (p<0.001) glucose transport capacity and jejunal O consumption between d26 and hatch. Jejunal weight adjusted for (Table 1) . This is an ontological adaptation to prepare embryonic or body weight increased 64% between d26 embryos for hatch (Sell et al., 1991) . Similar increases and hatch (p<0.001; 3.95 ± 0.10 versus 6.49 ± 0.19, in intestinal density and glucose absorption have been respectively).
reported during this period by Hinni and Watterson Total glucose uptake (Table 1) did not change from d20 (1963) . They found these changes in chick embryos to to d23; however, it increased between d23, d26 and be largely completed during the 3-day period preceding hatch (p<0.001). This increase in total uptake reflects hatch. Morphological studies on poults have changes in active glucose transport (Table 1) . The level documented an increase in the height of epithelial cells of active glucose transport increased 400% between and the length and density of epithelial microvilli during d20 and hatch (p<0.001; 82.84 ± 5.25 vs 363.19 ± 39.9).
this time period (Overton and Shoup, 1964; Grey, 1972) . Passive glucose transport decreased with day o f Both changes may be positively correlated with intestinal incubation (Table 1) . Furthermore, the ratio of active to maturation (Black, 1978) . These structural changes are passive transport (Fig. 1) increased significantly accompanied by dramatic rises in constituent enzyme (p<0.01) from incubation to hatch (1/1 at d20, 2/1 at d23, activity, including phosphatases and disaccharidases 3/1 at d26, and 10/1 on day of hatch). Jejunal oxygen on the microvillus membranes, as well as glucose consumption between d26 and hatch (Table 1 ) oxidation (Strittmatter, 1973; Black and Moog, 1978) . increased 8.6% (p< 0.01). APEE decreased from d26 to It is interesting that in Trial 1, the period of maximum hatch ( Fig. 1; p<0 .001); representing a corresponding increased jejunal growth and increased tissue oxygen increase in the overall efficiency of active glucose consumption (d26 and hatch; Table 1 ) was uptake.
accompanied by an increase in the apparent energetic Trial 2: Body weights of embryos increased between enzyme activities in enterocyte intestinal absorptive cell d23 and hatch in both control and PYY treated eggs culture systems found evidence for complex hormonal (p<0.01; Table 2), however, no significant differences control during maturation (Corradino, 1979; Peterlik et (p>0.05) were found between control and PYY al., 1981) . Further studies are needed to more fully treatments. A significant increase (p<0.05) in adjusted understand the physiological basis of these structural jejunal weight was observed in poults from PYY treated and metabolic changes and their impact on absorptive eggs compared to controls (p<0.05; Table 2 ). Jejunal efficiency. length, corrected for body weight, was decreased
In Trial 2, eggs were injected with PYY to investigate the (p<0.05) by PYY administration at d26 of incubation.
effects of this peptide on jejunal growth and the Total glucose uptake was significantly (p<0.01) reduced development of glucose transport during incubation. PYY in the PYY treated poults at hatch. The difference at hatch is known to modify digestive processes to ensure (p<0.01; 394 ± 10 versus 335 ± 16) was primarily the efficient utilization of ingested food (Hallden and Aponte,
Discussion
In Trial 1, we further described the developmental 2 efficiency of glucose transport (Fig. 1) . Investigations of Control vs. hatch PYY. *= p < 0.05, **= p < 0.01, ***= p < 0.001 4 1997). Peptide YY exerts its effects by inhibiting gut In Trial 2, no significant differences were found in jejunal motility and secretions from the intestinal lumen and weight and glucose transport between embryos from pancreas (Savage et al., 1987; Hallden and Aponte, control and PYY treated eggs, (Table 2) , although similar 1997). Previous studies from this laboratory, using mice, differences were noted in jejunal weight, as in Trial 1, have documented that exogenous administration of PYY between d26 and hatch. Poults from PYY treated eggs increases intestinal glucose absorption and increases had heavier jejunal weights relative to length at hatch. the energetic efficiency of glucose absorption (Bird et al., This increase in intestinal mass was accompanied by 1996). Additionally, studies have found that exogenous significantly less active glucose uptake than the control administration of PYY in vivo is trophic to intestinal group at hatch. The energetic efficiency of jejunal active tissues (Chance et al., 1998) . Berg et al. (2000) has glucose transport (Fig. 2) was also less for the PYY reported that subcutaneous administration of PYY, at group. Although PYY enhanced jejunal growth in the final 300µg/kg body weight for 3 days to mice, increases stages of embryonic development, it decreased the rate adjusted jejunal weight. Goodlad et al. (1990) , however, of active glucose uptake as well as the APEE. reported that administration of PYY to rats for 3 days had
The reason for the failure of PYY to enhance the rate and no effect on intestinal cell proliferation. In ovo PYY efficiency of jejunal glucose transport in BUT turkey administration to turkey eggs enhanced growth and feed poults is unclear. In the present study, the dosage used conversion ratios at one week post-hatch for chicks and was 400µg PYY/kg egg weight. Coles et al. (2000) have growth at 3 days post-hatch for poults (Coles et al., described significant variation in genotypic response to 1999 (Coles et al., described significant variation in genotypic response to , 2000 . Both of these responses suggest a PYY. They reported that in ovo administration of PYY potential role for PYY as a regulator of intestinal enhanced jejunal glucose transport of hatchlings a t maturation and nutrient absorption during the first week 600µg/kg in egg weight Nicholas and Egg Line poults post-hatch. and 900µg/kg egg weight in BUT line poults. Hence, the Other physiological factors may have contributed to the lack of effect of PYY in Trial 2. The efficacy of in ovo administration of PYY into the air sac is predicated on the assumption that sufficient quantities of the peptide is absorbed by the embryonic membranes of the egg and systemically transferred to the embryo. Unknown differences in embryonic membrane permeability between turkey lines may explain, in part, the genotype versus dosage variation discussed by Coles et al. (2000) . Additionally, the responses of young poults to diets varying in nutrient composition may be a factor. Recently, Suvarna et al. (2005) reported that the plasma thyroid hormone T , concentration for BUT turkey poults 3 increased during the feeding of a high carbohydrate diet. Tovar et al. (2004) reported decreased circulating PYY levels in hyperthyroid rats. It is possible that a nutrient x genotype interaction may play a role in endogenous circulation PYY levels. This, in turn, may affect response to exogenous PYY administration. Further studies are needed to clarify the factors affecting PYY's effect on nutrient transport in turkey's before a consistent and efficacious protocol can be described for the use of PYY in poultry production systems. 
